Brain MR findings in patients with systemic lupus erythematosus with and without antiphospholipid antibody syndrome

American Journal of Neuroradiology

Volumn 35, Issue 1, 2014, Pages 100-105

  Kaichi, Y ^a,b   Kakeda, Shingo ^a   Moriya, J ^a   Ohnari, N ^a   Saito, K ^a   Tanaka, Y ^a   Tatsugami, F ^b   Date, S ^b   Awai, K ^b   Korogi, Y ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERY OCCLUSION; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONTROLLED STUDY; CORPUS CALLOSUM; CORRELATION ANALYSIS; FEMALE; HUMAN; IMAGE ANALYSIS; LACUNAR STROKE; LOGISTIC REGRESSION ANALYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; NEUROIMAGING; SYSTEMIC LUPUS ERYTHEMATOSUS; WHITE MATTER;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BRAIN; FEMALE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84892770077     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3645     Document Type: Article

References (34)

1. Johnson RT, Richardson EP. The neurological manifestations of systemic lupus erythematosus. Medicine 1968;47:337-69
2. O'Connor JF, Musher DM. Central nervous system involvement in systemic lupus erythematosus: a study of 150 cases. Arch Neurol 1966;14:157-64
3. Sibbitt WL Jr, Brooks WM, Kornfeld M, et al. Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 2010;40:32-52
4. Kim JH, Choi CG, Choi SJ, et al. Primary antiphospholipid antibody syndrome: neuroradiologic findings in 11 patients. Korean J Radiol 2000;1:5-10
5. Golstein M, Meyer O, Bourgeois P, et al. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies. Clin Exp Rheumatol 1993;11:373-79
6. Bertolaccini ML, Gomez S, Pareja JF, et al. Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis 2005;64:1639-43
7. Rodriguez Garcia JL, Khamashta MA. Clinical advances of interest in the diagnosis and treatment of patients with antiphospholipid syndrome. Rev Clin Esp 2013;213:108-13
8. Bertsias GK, Ioannidis JP, Aringer M, et al. Eular recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the Eular Standing Committee for Clinical Affairs. Ann Rheum Dis 2010;69:2074-82
9. Harris EN, Gharavi AE, Asherson RA, et al. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984;2:47-51
10. Harris EN, Gharavi AE, Mackworth, et al. Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies. Ann Rheum Dis 1985;44:281-83
11. Valdes-Ferrer SI, Vega F, Cantu-Brito C, et al. Cerebral changes in SLE with or without antiphospholipid syndrome: a case-control MRI study. J Neuroimaging 2008;18:62-65
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725
13. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite anti-phospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11
14. Lodder J, Hupperts R, Boreas A, et al. The size of territorial brain infarction on CT relates to the degree of internal carotid artery obstruction. J Neurol 1996;243:345-49
15. Bang OY, Ovbiagele B, Liebeskind DS, et al. Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke. J Neurol 2009;256:591-99
16. Kimura K, Minematsu K, Koga M, et al. Microembolic signals and diffusion-weighted MR imaging abnormalities in acute ischemic stroke. AJNR Am J Neuroradiol 2001;22:1037-42
17. Bogousslavsky J, Regli F. Unilateral watershed cerebral infarcts. Neurology 1986;36:373-77
18. Damasio H. A computed tomographic guide to the identification of cerebral vascular territories. Arch Neurol 1983;40:138-42
19. Fisher CM. Lacunar strokes and infarcts: a review. Neurology 1982;32:871-76
20. Fazekas F, Kleinert R, Offenbacher H, et al. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol 1991;12:915-21
21. Wuerfel J, Haertle M, Waiczies H, et al. Perivascular spaces: MRI marker of inflammatory activity in the brain? Brain 2008;131:2332-40
22. Chao CP, Kotsenas AL, Broderick DF. Cerebral amyloid angiopathy: CT and MR imaging findings. Radiographics 2006;26:1517-31
23. Aron AL, Gharavi AE, Shoenfeld Y. Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome. Int Arch Allergy Immunol 1995;106:8-12
24. Duvernoy HM, Delon S, Vannson JL. Cortical blood vessels of the human brain. Brain Res Bull 1981;7:519-79
25. Derdeyn CP, Khosla A, Videen TO, et al. Severe hemodynamic impairment and border zone-region infarction. Radiology 2001;220: 195-201
26. Torvik A. The pathogenesis of watershed infarcts in the brain. Stroke 1984;15:221-23
27. Chaves CJ, Silver B, Schlaug G, et al. Diffusion- and perfusion-weighted MRI patterns in borderzone infarcts. Stroke 2000; 31:1090-96
28. Atsumi T, Khamashta MA, Haworth RS, et al. Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1. Arthritis Rheum 1998;41:800-07
29. Karussis D, Leker RR, Ashkenazi A, et al. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol 1998;44:629-34
30. Sabet A, Sibbitt WL Jr, Stidley CA, et al. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke 1998;29:2254-60
31. Hachulla E, Michon-Pasturel U, Leys D, et al. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies. Lupus 1998;7:124-31
32. Provenzale JM, Barboriak DP, Allen NB, et al. Patients with antiphospholipid antibodies: CT and MR findings of the brain. AJR 1996;167:1573-78
33. Asherson RA, Mercey D, Phillips G, et al. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 1987; 46:605-11
34. Provenzale JM, Heinz ER, Ortel TL, et al. Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings. Radiology 1994;192:531-37